NYSE:BAX - Baxter International Stock Price, Price Target & More

Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."

Baxter International announced a quarterly dividend on Tuesday, May 8th. Stockholders of record on Friday, June 1st will be paid a dividend of $0.19 per share on Monday, July 2nd. This represents a $0.76 annualized dividend and a dividend yield of 1.02%. The ex-dividend date of this dividend is Thursday, May 31st. This is an increase from Baxter International's previous quarterly dividend of $0.16. View Baxter International's Dividend History.

Baxter International declared that its board has authorized a share buyback plan on Wednesday, February 21st 2018, which permits the company to buyback $1,500,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization permits the company to reacquire shares of its stock through open market purchases. Stock buyback plans are generally an indication that the company's management believes its shares are undervalued.

Baxter International Inc (NYSE:BAX) issued its earnings results on Thursday, April, 26th. The medical instruments supplier reported $0.70 earnings per share for the quarter, beating the consensus estimate of $0.62 by $0.08. The medical instruments supplier had revenue of $2.68 billion for the quarter, compared to analysts' expectations of $2.62 billion. Baxter International had a net margin of 7.75% and a return on equity of 15.70%. The business's revenue was up 8.2% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.58 EPS. View Baxter International's Earnings History.

Baxter International is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Baxter International.

Baxter International updated its FY18 earnings guidance on Thursday, April, 26th. The company provided earnings per share (EPS) guidance of $2.85-2.93 for the period, compared to the Thomson Reuters consensus earnings per share estimate of $2.78. The company issued revenue guidance of $11.3-11.4 billion, compared to the consensus revenue estimate of $11.25 billion.Baxter International also updated its Q2 guidance to $0.69-0.71 EPS.

16 Wall Street analysts have issued 1-year price objectives for Baxter International's stock. Their predictions range from $62.00 to $83.00. On average, they anticipate Baxter International's stock price to reach $72.7333 in the next twelve months. This suggests that the stock has a possible downside of 2.7%. View Analyst Ratings for Baxter International.

16 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 6 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."

Some companies that are related to Baxter International include 3M (MMM), Becton Dickinson and (BDX), Stryker (SYK), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), Dexcom (DXCM), ICU Medical (ICUI), Hill-Rom (HRC), Globus Medical (GMED), Insulet (PODD), Haemonetics (HAE) and Penumbra (PEN).

News coverage about BAX stock has been trending somewhat positive on Sunday, Accern Sentiment reports. The research firm identifies negative and positive news coverage by analyzing more than twenty million blog and news sources in real time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Baxter International earned a daily sentiment score of 0.07 on Accern's scale. They also gave press coverage about the medical instruments supplier an impact score of 47.53 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the near future.

Baxter International's stock is owned by many different of institutional and retail investors. Top institutional shareholders include Gateway Investment Advisers LLC (0.08%), NN Investment Partners Holdings N.V. (0.05%), Gulf International Bank UK Ltd (0.03%), Fjarde AP Fonden Fourth Swedish National Pension Fund (0.03%), Handelsbanken Fonder AB (0.03%) and Xact Kapitalforvaltning AB (0.02%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.

BAX stock was sold by a variety of institutional investors in the last quarter, including NN Investment Partners Holdings N.V., Gateway Investment Advisers LLC, CenturyLink Investment Management Co, Ledyard National Bank, BLB&B Advisors LLC, First Citizens Bank & Trust Co., Legacy Private Trust Co. and Private Trust Co. NA. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.

BAX stock was bought by a variety of institutional investors in the last quarter, including Handelsbanken Fonder AB, Gulf International Bank UK Ltd, State of Alaska Department of Revenue, Fjarde AP Fonden Fourth Swedish National Pension Fund, IFM Investors Pty Ltd, DnB Asset Management AS, Xact Kapitalforvaltning AB and Mitchell Sinkler & Starr PA. View Insider Buying and Selling for Baxter International.

Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of BAX stock can currently be purchased for approximately $74.78.

Baxter International has a market capitalization of $40.04 billion and generates $10.56 billion in revenue each year. The medical instruments supplier earns $717 million in net income (profit) each year or $2.48 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.

Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]